US Broker Ratings

Alvotech (ALVO) Stock Analysis: Unveiling a 92.72% Potential Upside in the Biosimilar Market

For investors seeking opportunities in the healthcare sector, Alvotech (NASDAQ: ALVO) presents a compelling case with a notable potential upside of 92.72%. This Luxembourg-based company is carving out a niche..

Scholar Rock Holding Corporation (SRRK) Investor Outlook: A 54.58% Potential Upside Beckons

Scholar Rock Holding Corporation (NASDAQ: SRRK), a dynamic player in the biotechnology sector, has piqued investor interest with its promising pipeline in the healthcare industry. Headquartered in Cambridge, Massachusetts, this..

Metsera, Inc. (MTSR) Stock Analysis: Exploring a Promising 86% Upside in Biotechnology

Metsera, Inc. (MTSR), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to tackling obesity and related disorders. Headquartered in New York, Metsera focuses..

Amedisys Inc (AMED) Investor Outlook: Navigating Market Challenges in the Healthcare Sector

Amedisys Inc (AMED), a prominent player in the healthcare sector, continues to attract attention from investors seeking opportunities in the medical care facilities industry. With a market capitalization of $3.19..

PROCEPT BioRobotics (PRCT) Stock Analysis: A 27% Potential Upside Amid Robust Revenue Growth

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) has been a standout performer in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $3.34 billion, this U.S.-based company..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring a 15.86% Upside Potential in the Eye Health Market

Bausch + Lomb Corporation (NYSE: BLCO) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $4.42 billion,..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 32.62% Upside Potential in Rare Disease Biotech

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands at the forefront of biotechnology with a focus on rare neuroendocrine diseases. As a commercial-stage biopharmaceutical entity, Rhythm’s market capitalization has soared to $4..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Strong Buy Ratings and 16.75% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector, has captured the attention of investors with its robust performance and promising growth prospects. Specializing in the..

RadNet, Inc. (RDNT) Stock Analysis: A 29% Upside Potential in the Healthcare Diagnostics Sector

RadNet, Inc. (NASDAQ: RDNT) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With its expansive network of outpatient diagnostic imaging services in the United..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a 41.73% Upside in the Biotech Space

Telix Pharmaceuticals Limited (TLX), an innovative player in the biotechnology sector, is making waves with its promising pipeline of radiopharmaceutical products aimed at treating cancer and rare diseases. Headquartered in..

Elanco Animal Health (ELAN): Investor Outlook with a 7.63% Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN) presents an intriguing opportunity for investors in the healthcare sector, specifically in the niche of animal health. As a company with a significant global..

Guardant Health, Inc. (GH) Stock Analysis: Unlocking a 21% Potential Upside in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH), a pioneering force in the healthcare sector, specifically within the Diagnostics & Research industry, is captivating investor interest with its formidable growth potential. With a..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring a 40% Potential Upside in the Biotech Arena

Investors with a keen interest in the biotechnology sector are increasingly setting their sights on Soleno Therapeutics, Inc. (NASDAQ: SLNO), an intriguing player focused on rare disease therapeutics. With a..

Verona Pharma plc (VRNA) Stock Analysis: Is This $7.84 Billion Biotech a Breath of Fresh Air for Investors?

Verona Pharma plc (NASDAQ: VRNA), a biopharmaceutical company rooted in the United Kingdom, stands at the forefront of innovation within the respiratory disease sector. With a market capitalization of $7.84..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 38.53% Upside Potential for Investors

Bio-Rad Laboratories, Inc. (NYSE: BIO), a veteran in the healthcare sector, is a prominent player in the medical devices industry. Founded in 1952 and headquartered in Hercules, California, the company..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Examining a 43% Upside Potential in Biotechnology

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), headquartered in West Conshohocken, Pennsylvania, is making waves in the biotechnology industry, a sector renowned for its high stakes and high rewards. Specializing in the..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a 9.21% Potential Upside in the Healthcare Sector

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, has become a focal point for investors seeking exposure to medical care facilities. With a market capitalization..

Corcept Therapeutics (CORT) Investor Outlook: Nearly 100% Upside Potential Awaits

Corcept Therapeutics Incorporated (NASDAQ: CORT), a dynamic player in the biotechnology sector, is capturing investor attention with its robust pipeline and impressive potential upside. With a market capitalization of $7.43..

Option Care Health, Inc. (OPCH) Investor Outlook: Analyzing a 22% Potential Upside in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector, is making waves with its extensive range of home and alternate site infusion services across the United..

Integer Holdings Corporation (ITGR) Stock Analysis: Unlocking a 25.74% Upside Potential in Healthcare

Integer Holdings Corporation (NYSE: ITGR) has carved out a prominent position in the healthcare sector as a leading medical device contract development and manufacturing company. With its extensive portfolio that..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds